Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA9 | Q16790 | 4/20 | 0.37 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514092 | 0.95 | MCHR1 (0.46) | SMN1; SMN2MCHR1ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL524732 | 0.95 | MCHR1 (0.46) | SMN1; SMN2MCHR1ALDH1A1CYP2C9CYP3A4 | |
| Hexadecylamine SCHEMBL7554404 | 0.90 | MCHR1 (0.42) | SMN1; SMN2MCHR1ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL8725762 | 0.89 | MCHR1 (0.42) | SMN1; SMN2MCHR1ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL306553 | 0.85 | SMN1; SMN2 (0.41) | SMN1; SMN2MCHR1ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL3671895 | 0.85 | GAA (0.44) | SMN1; SMN2ALDH1A1CYP2C9CYP3A4CYP2C19 | |
| SCHEMBL1638890 | 0.85 | TDP1 (0.45) | SMN1; SMN2ALDH1A1TDP1TSHRHSP90AA1 | |
| SCHEMBL9240349 | 0.83 | RAPGEF4 (0.33) | ALDH1A1TDP1TSHRGAACA12 | |
| SCHEMBL16908425 | 0.82 | GAA (0.45) | SMN1; SMN2ALDH1A1CYP2C9CYP3A4CYP2C19 | |
| SCHEMBL4607771 | 0.81 | CA2 (0.54) | SMN1; SMN2ALDH1A1CYP3A4LMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658387-A2 | ATMOSPHERIC WATER GENERATION SYSTEMS ENCOMPASSING HYGROSCOPIC MEDIA AND METHODS OF USING THE SAME | Genesis Systems LLC (US) | 2025-12-10 | — | — | EP | claimed |
| EP-3275039-B1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF CORP (US) | 2025-08-27 | — | — | EP | claimed |
| CN-119823109-A | An electrochromic material electrochromic composition and electrochromic device | 吉林大学 | 2025-04-15 | — | — | CN | claimed |
| WO-2024163325-A2 | ATMOSPHERIC WATER GENERATION SYSTEMS ENCOMPASSING HYGROSCOPIC MEDIA AND METHODS OF USING THE SAME | GENESIS SYSTEMS LLC (US) | 2024-08-08 | — | — | WO | claimed |
| CN-115010836-B | Electrochromic polymer, nano particle and device | 吉林大学 | 2023-09-08 | — | — | CN | claimed |
| EP-3684745-B1 | INLINE PROCESS TO MAKE ANTIFOULING AGENT CO-CATALYST FOR ETHYLENE OLIGOMERIZATION | SAUDI ARABIAN OIL CO (SA) | 2023-07-19 | — | — | EP | claimed |
| US-11567385-B2 | Electrochromic device | THE BOEING COMPANY (US) | 2023-01-31 | — | — | US | claimed |
| CN-111094219-B | In-line process for preparing antifouling agent cocatalyst for ethylene oligomerization | 沙特阿拉伯石油公司 | 2022-10-14 | — | — | CN | claimed |
| EP-3753973-B1 | A METHOD FOR SEALING A GAP BETWEEN ADJOINING OR CONNECTED SOLID SURFACES ON AN AIRCRAFT | BOEING CO (US) | 2022-09-28 | — | — | EP | claimed |
| US-20220280927-A1 | ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-09-08 | — | — | US | claimed |
| US-20160285130-A1 | Electrolytes and Metal Hydride Batteries | U.S. DEPARTMENT OF ENERGY | 2016-09-29 | — | — | US | claimed |
| US-9449797-B2 | Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface | LAM RESEARCH CORPORATION (US) | 2016-09-20 | — | — | US | claimed |
| US-20160141726-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | claimed |
| US-20160141727-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | claimed |
| US-9120834-B2 | Membrane separation of ionic liquid solutions | CMS TECHNOLOGIES HOLDINGS, INC. (US) | 2015-09-01 | — | — | US | claimed |
| WO-2015066245-A1 | MEMBRANE SEPARATION OF IONIC LIQUID SOLUTIONS | CMS TECHNOLOGIES HOLDINGS, INC. (US) | 2015-05-07 | — | — | WO | claimed |
| US-20150119577-A1 | Membrane Separation of Ionic Liquid Solutions | CMS TECHNOLOGIES HOLDINGS, INC. (US) | 2015-04-30 | — | — | US | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| US-8217100-B2 | Adhesive composition and optical member | CHEIL INDUSTRIES, INC. (KR) | 2012-07-10 | — | — | US | claimed |
| US-20090014123-A1 | Adhesive composition and optical member | Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) | 2009-01-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220280927-A1 | ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS | PFAS, PUF60, AS3MT | SMN1; SMN2 3238/4885MCHR1 3273/4885ALDH1A1 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.